Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus

摘要

Hydroxychloroquine (HCQ) is a mainstay of therapy in the treatment of SLE. The effect of HCQ on platelets and vascular health is uncertain. We investigated the relationship between HCQ use and dose with platelet activity, platelet transcriptomics and vascular health in patients with SLE.